Teva Innovative Medicine & Biosimilar Pipeline
By development stage – as of May 2024
Technology Platforms:
Phase 3
Phase 2
Phase 1
Pre-clinical
Download a PDF version of Teva Innovative Medicine and Biosimilar Pipeline
Download PDFTeva innovative medicine and biosimilar pipeline by development stage, excluding country / regional launches of products submitted or under review in new markets.
Pipeline is current as of May 2024.
-
Back to contents.
In collaboration with MODAG.
-
Back to contents.
In collaboration with Sanofi.
-
Back to contents.
In collaboration with Alvotech for the U.S. market.
-
Back to contents.
In collaboration with Launch Therapeutics.
-
Back to contents.
In collaboration with mAbxience.